MODIFICATION TO THE EMIT II PLUS COCAINE METABOLITE ASSAY

Enzyme Immunoassay, Cocaine And Cocaine Metabolites

SYVA CO., DADE BEHRING, INC.

The following data is part of a premarket notification filed by Syva Co., Dade Behring, Inc. with the FDA for Modification To The Emit Ii Plus Cocaine Metabolite Assay.

Pre-market Notification Details

Device IDK011162
510k NumberK011162
Device Name:MODIFICATION TO THE EMIT II PLUS COCAINE METABOLITE ASSAY
ClassificationEnzyme Immunoassay, Cocaine And Cocaine Metabolites
Applicant SYVA CO., DADE BEHRING, INC. 3403 YERBA BUENA RD. San Jose,  CA  95135
ContactSusan Collins
CorrespondentSusan Collins
SYVA CO., DADE BEHRING, INC. 3403 YERBA BUENA RD. San Jose,  CA  95135
Product CodeDIO  
CFR Regulation Number862.3250 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2001-04-16
Decision Date2001-05-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.